Raheel Shafi

1.0k total citations · 1 hit paper
5 papers, 664 citations indexed

About

Raheel Shafi is a scholar working on Rheumatology, Physiology and Molecular Biology. According to data from OpenAlex, Raheel Shafi has authored 5 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Rheumatology, 3 papers in Physiology and 2 papers in Molecular Biology. Recurrent topics in Raheel Shafi's work include Glycogen Storage Diseases and Myoclonus (3 papers), Lysosomal Storage Disorders Research (3 papers) and Glycosylation and Glycoproteins Research (1 paper). Raheel Shafi is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (3 papers), Lysosomal Storage Disorders Research (3 papers) and Glycosylation and Glycoproteins Research (1 paper). Raheel Shafi collaborates with scholars based in United States, France and United Kingdom. Raheel Shafi's co-authors include Lesley G. Ellies, Sai Prasad N. Iyer, Kurt W. Marek, Daniel Chui, Jamey D. Marth, Gerald W. Hart, David Giron, D. Roselyn Cerutis, Richard E. Hillman and John Day and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Journal of Medical Virology.

In The Last Decade

Raheel Shafi

4 papers receiving 656 citations

Hit Papers

The O-GlcNAc transferase gene resides on the X chromosome... 2000 2026 2008 2017 2000 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raheel Shafi United States 3 596 347 287 63 56 5 664
Denise Karaoglu United States 9 539 0.9× 176 0.5× 192 0.7× 46 0.7× 43 0.8× 11 671
Su-Il Do South Korea 12 389 0.7× 168 0.5× 192 0.7× 30 0.5× 9 0.2× 20 439
Esther Maldener Germany 11 470 0.8× 107 0.3× 118 0.4× 25 0.4× 264 4.7× 11 590
Romain Péanne Belgium 9 416 0.7× 119 0.3× 142 0.5× 123 2.0× 16 0.3× 11 576
Mitsutaka Ogawa Japan 16 433 0.7× 130 0.4× 144 0.5× 26 0.4× 5 0.1× 31 492
Sarah Garrett United States 7 444 0.7× 87 0.3× 65 0.2× 54 0.9× 24 0.4× 8 638
Mehrab Nasirikenari United States 13 391 0.7× 71 0.2× 283 1.0× 28 0.4× 5 0.1× 21 520
Dominique Klein Switzerland 8 342 0.6× 51 0.1× 88 0.3× 37 0.6× 26 0.5× 12 408
Daisy Rymen Belgium 11 248 0.4× 59 0.2× 78 0.3× 82 1.3× 11 0.2× 23 380
Riccardo Trapannone Austria 8 490 0.8× 97 0.3× 123 0.4× 50 0.8× 17 0.3× 10 717

Countries citing papers authored by Raheel Shafi

Since Specialization
Citations

This map shows the geographic impact of Raheel Shafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raheel Shafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raheel Shafi more than expected).

Fields of papers citing papers by Raheel Shafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raheel Shafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raheel Shafi. The network helps show where Raheel Shafi may publish in the future.

Co-authorship network of co-authors of Raheel Shafi

This figure shows the co-authorship network connecting the top 25 collaborators of Raheel Shafi. A scholar is included among the top collaborators of Raheel Shafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raheel Shafi. Raheel Shafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
2.
Trivedi, Jaya, Ans van der Ploeg, Richard J. Barohn, et al.. (2016). Phase 1 Safety and Pharmacokinetics of the Novel Enzyme Replacement Therapy neoGAA in Treatment-Naïve and Alglucosidase Alfa-Treated Late-Onset Pompe Disease Patients (S38.005). Neurology. 86(16_supplement). 1 indexed citations
3.
Thurberg, Beth L., Pierre G. Carlier, John T. Kissel, et al.. (2015). A Phase 4 Prospective Study in Patients with Adult Pompe Disease Treated with Alglucosidase Alfa. Journal of Neuromuscular Diseases. 2(s1). S72–S73. 1 indexed citations
4.
Shafi, Raheel, Sai Prasad N. Iyer, Lesley G. Ellies, et al.. (2000). The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proceedings of the National Academy of Sciences. 97(11). 5735–5739. 629 indexed citations breakdown →
5.
Shafi, Raheel, D. Roselyn Cerutis, & David Giron. (1993). Pathogenesis of the B variant of encephalomyocarditis virus. Journal of Medical Virology. 40(3). 193–199. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026